Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans

American Journal of Clinical Nutrition

Volumn 69, Issue 6, 1999, Pages 1086-1107

  Carr, Anitra C ^b   Frei, Balz ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b NONE

Author keywords

Adults; Antioxidant; Cancer; Cardiovascular disease; Cataract; DNA; Lipid; Protein; Recommended dietary allowance; Vitamin C

Indexed keywords

ASCORBIC ACID;

ANTIOXIDANT ACTIVITY; ASCORBIC ACID DEFICIENCY; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CATARACT; CHRONIC DISEASE; CLINICAL TRIAL; DIETARY INTAKE; DNA DAMAGE; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; REVIEW; SCURVY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 0032977279     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.6.1086     Document Type: Review

References (238)

1. Jaffe GM. Vitamin C. In: Machlin L, ed. Handbook of vitamins. New York: Marcel Dekker Inc, 1984:199-244.
2. Woodall AA, Ames BN. Diet and oxidative damage to DNA: the importance of ascorbate as an antioxidant. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:193-203.
3. Bendich A. Vitamin C safety in humans. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:367-79.
4. Levine M. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 1986;314:892-902.
5. Weber P, Bendich A, Schalch W. Vitamin C and human health - a review of recent data relevant to human requirements. Int J Vitam Nutr Res 1996;66:19-30.
6. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989.
7. Young VR. Evidence for a recommended dietary allowance for vitamin C from pharmacokinetics: a comment and analysis. Proc Natl Acad Sci U S A 1996;93:14344-8.
8. Burri BJ, Jacob RA. Human metabolism and the requirement for vitamin C. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:341-66.
9. Tsao CS. An overview of ascorbic acid chemistry and biochemistry. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:25-58.
10. Phillips CL, Yeowell HN. Vitamin C, collagen biosynthesis, and aging. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:205-30.
11. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo. Free Radic Res 1996;25:439-54.
12. Bendich A, Cohen M. Ascorbic acid safety: analysis of factors affecting iron absorption. Toxicol Lett 1990;51:189-201.
13. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 1994;269:9397-400.
14. Enstrom JE. Vitamin C in prospective epidemiological studies. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:381-98.
15. Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. Biofactors 1998;7:113-74.
16. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 1989;86:6377-81.
17. Frei B, Stocker R, England L, Ames BN. Ascorbate: the most effective antioxidant in human blood plasma. Adv Exp Med Biol 1990;264:155-63.
18. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes. Washington, DC: National Academy Press, 1998.
19. Niki E, Noguchi N. Protection of human low-density lipoprotein from oxidative modification by vitamin C. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:183-92.
20. Packer L. Vitamin C and redox cycling antioxidants. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:95-121.
21. Bowry VW, Mohr D, Cleary J, Stocker R. Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J Biol Chem 1995;270:5756-63.
22. Neuzil J, Thomas SR, Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med 1997;22:57-71.
23. Edge R, Truscott TG. Prooxidant and antioxidant reaction mechanisms of carotene and radical interactions with vitamins E and C. Nutrition 1997;13:992-4.
24. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate. Arch Biochem Biophys 1993;300:535-43.
25. Wells WW, Jung C. Regeneration of vitamin C. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:109-21.
26. Monsen ER. New dietary reference intakes proposed to replace the recommended dietary allowances. J Am Diet Assoc 1996;96:754-5.
27. Food labeling; nutrient content claims: definition for "high potency" and definition of "antioxidant" for use in nutrient content claims for dietary supplements and conventional foods. Docket no. 95N-0347. Fed Regist 1997;62:49868-81.
28. Bucala R. Lipid and lipoprotein oxidation: basic mechanisms and unresolved questions in vivo. Redox Rep 1996;2:291-307.
29. Berger TM, Polidori MC, Dabbagh A, et al. Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 1997;272:15656-60.
30. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993;90:7915-22.
31. Frei B. Vitamin C as an antiatherogen: mechanisms of action. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:163-82.
32. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-90.
33. Heinecke JW. Cellular mechanisms for the oxidative modification of lipoproteins: implications for atherogenesis. Coron Artery Dis 1994;5:205-10.
34. Keaney JF, Frei B. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In: Frei B, ed. Natural antioxidants in human health and disease. San Diego: Academic Press Inc, 1994:303-51.
35. Heinecke JW. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine. Biofactors 1997;6:145-55.
36. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998;141:1-15.
37. McCall MR, Frei B. Mechanism(s) of LDL oxidation. In: Keaney JF, ed. Oxidative stress and vascular disease. Norwell, MA: Kluwer Academic Press (in press).
38. Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
39. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 1996;97:1535-44.
40. 2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1997;17:3236-41.
41. 2-isoprostanes in human atherosclerotic lesions. J Clin Invest 1997;100:2028-34.
42. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
43. Lynch SM, Gaziano JM, Frei B. Ascorbic acid and atherosclerotic cardiovascular disease. In: Harris JR, ed. Ascorbic acid: biochemistry and biomedical cell biology. New York: Plenum Press, 1996:331-67.
44. Lynch SM, Frei B. Antioxidants as antiatherogens: animal studies. In: Frei B, ed. Natural antioxidants in human health and disease. San Diego: Academic Press Inc, 1994:353-85.
45. Kehrer JP, Smith CV. Free radicals in biology: sources, reactivities, and roles in the etiology of human diseases. In: Frei B, ed. Natural antioxidants in human health and disease. San Diego: Academic Press Inc, 1994:25-62.
46. Comstock GW, Alberg AJ, Huang H, et al. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, α-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev 1997;6:907-16.
47. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993;362:709-15.
48. Asami S, Manabe H, Miyake J, et al. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site in the human lung. Carcinogenesis 1997;18:1763-6.
49. Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992;13:2241-7.
50. Prieme H, Loft S, Klarlund M, Gronbaek K, Tonnesen P, Poulsen HE. Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion. Carcinogenesis 1998;19:347-51.
51. Musarrat J, Arezina-Wilson J, Wani AA. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer 1996;32:1209-14.
52. Malins DC, Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 1991;51:5430-2.
53. Poulsen HE, Prieme H, Loft S. Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev 1998;7:9-16.
54. Taylor A, Dorey CK, Nowell T. Oxidative stress and ascorbate in relation to risk for cataract and age-related maculopathy. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:231-64.
55. Rose RC, Richer SP, Bode AM. Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med 1998;217:397-407.
56. Christen WG, Manson JE, Seddon JM, et al. A prospective study of cigarette smoking and risk of cataract in men. JAMA 1992;268:989-93.
57. Hankinson SE, Willet WC, Colditz GA, et al. A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA 1992;268:994-8.
58. Monnier VM, Sell DR, Nagaraj RH, et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging and uremia. Diabetes 1992;41:36-41.
59. de Zwart LL, Meerman JHN, Commandeur JNM, Vermeulen NPE. Biomarkers of free radical damage: applications in experimental animals and in humans. Free Radic Biol Med 1999;26:202-26.
60. McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 1999;26:1034-53.
61. Frei B, Yamamoto Y, Niclas D, Ames BN. Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma. Anal Biochem 1988;175:120-30.
62. Esterbauer H. Estimation of peroxidative damage: a critical review. Pathol Biol 1996;44:25-8.
63. Frei B, Gaziano JM. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res 1993;34:2135-45.
64. 2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1997;17:3230-5.
65. 2-isoprostanes) in smokers. N Engl J Med 1995;332:1198-203.
66. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 1994;93:998-1004.
67. McCall MR, Frei B. Antioxidant vitamins: evidence from biomarkers in humans. In: Walter P, ed. Evidence for vitamin functions beyond RDAs. Basel, Switzerland: Karger (in press).
68. Steinberg FM, Chait A. Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am J Clin Nutr 1998;68:319-27.
69. Nyyssonen K, Porkkala E, Salonen R, Korpela H, Salonen JT. Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial. Am J Clin Nutr 1994;48:633-42.
70. Abbey M, Noakes M, Nestel PJ. Dietary supplementation with orange and carrot juice in cigarette smokers lowers oxidation products in copper-oxidized low-density lipoproteins. J Am Diet Assoc 1995;95:671-5.
71. Jialal I, Grundy SM. Effect of combined supplementation with α-tocopherol, ascorbate, and β-carotene on low-density lipoprotein oxidation. Circulation 1993;88:2780-6.
72. Rifici VA, Khachadurian AK. Dietary supplementation with vitamins C and E inhibits in vitro oxidation of lipoproteins. J Am Coll Nutr 1993;12:631-7.
73. Gilligan DM, Sack MN, Guetta V, et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 1994;24:1611-7.
74. Mosca L, Rubenfire M, Mandel C, et al. Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease. J Am Coll Cardiol 1997;30:392-9.
75. Harats D, Ben-Naim M, Dabach Y, et al. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990;85:47-54.
76. Fuller CJ, Grundy SM, Norkus EP, Jialal I. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 1996;119:139-50.
77. Reilly M, Delanty N, Lawson JA, Fitzgerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996;94:19-25.
78. Mulholland CW, Strain JJ, Trinick TR. Serum antioxidant potential, and lipoprotein oxidation in female smokers following vitamin C supplementation. Int J Food Sci Nutr 1996;47:227-31.
79. Cadenas S, Rojas C, Mendez J, Herrero A, Barja G. Vitamin E decreases urine lipid peroxidation products in young healthy human volunteers under normal conditions. Pharmacol Toxicol 1996;79:247-53.
80. Nyyssönen K, Poulsen HE, Hayn M, et al. Effect of supplementation of smoking men with plain or slow-release ascorbic acid on lipoprotein oxidation. Eur J Clin Nutr 1997;51:154-63.
81. Samman S, Brown AJ, Beltran C, Singh S. The effect of ascorbic acid on plasma lipids and oxidisability of LDL in male smokers. Eur J Clin Nutr 1997;51:472-7.
82. Anderson D, Phillips BJ, Yu T, Edwards AJ, Ayesh R, Butterworth KR. The effects of vitamin C supplementation on biomarkers of oxygen radical generated damage in human volunteers with "low" or "high" cholesterol levels. Environ Mol Mutagen 1997;30:161-74.
83. Wen Y, Cooke T, Feely J. The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation. Br J Clin Pharmacol 1997;44:94-7.
84. Harats D, Chevion S, Nahir M, Norman Y, Sagee O, Berry EM. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between vitamins C and E in vivo. Am J Clin Nutr 1998;67:240-5.
85. Naidoo D, Lux O. The effect of vitamin C and E supplementation on lipid and urate oxidation products in plasma. Nutr Res 1998;18:953-61.
86. Gokce N, Keaney JF Jr, Frei B, et al. Chronic ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation (in press).
87. Jacob RA, Kutnink MA, Csallany AS, Daroszewska M, Burton GW. Vitamin C nutriture has little short-term effect on vitamin E concentrations in healthy women. J Nutr 1996;126:2268-77.
88. Cross CE, Halliwell B. Nutrition and human disease: how much extra vitamin C might smokers need? Lancet 1993;341:1091 (letter).
89. Jarvinen R, Knekt P. Vitamin C, smoking, and alcohol consumption. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:425-55.
90. Barja G, Lopez-Torres M, Perez-Campo R, et al. Dietary vitamin C decreases endogenous protein oxidative damage, malondialdehyde, and lipid peroxidation and maintains fatty acid unsaturation in the guinea pig liver. Free Radic Biol Med 1994;17:105-15.
91. Kimura H, Yamada Y, Morita Y, Ikeda H, Matsuo T. Dietary ascorbic acid depresses plasma and low density lipoprotein lipid peroxidation in genetically scorbutic rats. J Nutr 1992;122:1904-9.
92. Kunert KJ, Tappel AL. The effect of vitamin C on in vivo lipid peroxidation in guinea pigs as measured by pentane and ethane production. Lipids 1983;18:271-4.
93. Cadenas S, Lertsiri S, Otsuka M, Barga G, Miyazawa T. Phospholipid hydroperoxides and lipid peroxidation in liver and plasma of ODS rats supplemented with α-tocopherol and ascorbic acid. Free Radic Res 1996;24:485-93.
94. Do BK, Garewal HS, Clements NC, Peng YM, Habib MP. Exhaled ethane and antioxidant vitamin supplements in active smokers. Chest 1996;110:159-64.
95. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54(suppl):1113S-8S.
96. Collins AR, Dusinska M, Gedik CM, Stetina R. Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 1996;104:465-9.
97. Collins A, Cadet J, Epe B, Gedik C. Problems in the measurement of 8-oxoguanine in human DNA. Carcinogenesis 1997;18:1833-6.
98. Kow IH, Chen BX, Erlanger BF, Wallace SS. Antibodies to oxidative DNA damage: characterization of antibodies to 8-oxopurines. Cell Biol Toxicol 1997;13:405-17.
99. Fraga CG, Motchnik PA, Wyrobek AJ, Rempel DM, Ames BN. Smoking and low antioxidant levels increase oxidative damage to sperm DNA. Mutat Res 1996;351:199-203.
100. Fraga CG, Motchnik PA, Shigenaga MK, Helbock HJ, Jacob RA, Ames BN. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci U S A 1991;88:11003-6.
101. Green MHL, Lowe JE, Waugh APW, Aldridge KE, Cole J, Arlett CF. Effect of diet and vitamin C on DNA strand breakage in freshly-isolated human white blood cells. Mutat Res 1994;316:91-102.
102. Panayiotidis M, Collins AR. Ex vivo assessment of lymphocyte antioxidant status using the comet assay. Free Radic Res 1997;27:533-7.
103. Prieme H, Loft S, Nyyssonen K, Salonen JT, Poulsen HE. No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion in smokers, Am J Clin Nutr 1997;65:503-7.
104. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998;392:559 (letter).
105. Rehman A, Collis CS, Yang M, et al. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun 1998;246:293-8.
106. Levine MA, Daruwala RC, Park JB, Rumsey SC, Wang Y. Does vitamin C have a pro-oxidant effect? Nature 1998;395:231 (letter).
107. Poulsen HE, Weimann A, Salonen JT, et al. Does vitamin C have a pro-oxidant effect? Nature 1998;395:231-2 (letter).
108. Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 1996;56:1291-5.
109. Cadenas S, Barja G, Poulsen HE, Loft S. Oxidative DNA damage estimated by oxo8dG in the liver of guinea-pigs supplemented with graded dietary doses of ascorbic acid and α-tocopherol. Carcinogenesis 1997;18:2373-7.
110. Witt EH, Reznick Z, Viguie CA, Starke-Reed P, Packer L. Exercise, oxidative damage and effects of antioxidant manipulation. J Nutr 1992;122:766-73.
111. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997;272:20313-6.
112. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997;324:1-18.
113. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.
114. Ortwerth BJ, Monnier VM. Protein glycation by the oxidation products of ascorbic acid. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:123-42.
115. Cadenas S, Rojas C, Barja G. Endotoxin increases oxidative injury to proteins in guinea pig liver: protection by dietary vitamin C. Pharmacol Toxicol 1998;82:11-8.
116. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996;56:3238-43.
117. Levins M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 1996;93:3704-9.
118. Kallner A, Hartmann D, Hornig D. Steady-state turnover and body pool of ascorbic acid in man. Am J Clin Nutr 1979;32:530-9.
119. Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992;11:107-25.
120. Gatto LM, Hallen GK, Brown AJ, Samman S. Ascorbic acid induces favorable lipoprotein profile in women. J Am Coll Nutr 1996;15:154-8.
121. Ness AR, Khaw KT, Bingham S, Day NE. Vitamin C status and serum lipids. Eur J Clin Nutr 1996;50:724-9.
122. Toohey L, Harris MA, Allen KG, Melgy CL. Plasma ascorbic acid concentrations are related to cardiovascular risk factors in African-Americans. J Nutr 1996;126:121-8.
123. Simon JA, Hudes ES. Relation of serum ascorbic acid to serum lipids and lipoproteins in US adults. J Am Coll Nutr 1998;17:250-5.
124. 2 cholesterol. Am J Clin Nutr 1994;60:100-5.
125. Jacques PF. Effects of vitamin C on high-density lipoprotein cholesterol and blood pressure. J Am Coll Nutr 1992;11:139-44.
126. Woodward M, Lowe GD, Rumley A, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the third Glasco MONICA survey. Br J Haematol 1997;97:785-97.
127. Khaw KT, Woodhouse P. Interrelation of vitamin C, infection, hemostatic factors, and cardiovascular disease. BMJ 1995;310:1559-63.
128. Bordia AK. The effect of vitamin C on blood lipids, fibrinolytic activity and platelet adhesiveness in patients with coronary artery disease. Atherosclerosis 1980;35:181-7.
129. Bordia A, Verma SK. Effect of vitamin C on platelet adhesiveness and platelet aggregation in coronary artery disease patients. Clin Cardiol 1985;8:552-4.
130. Calzada C, Bruckdorfer KR, Rice-Evans CA. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 1997;128:97-105.
131. Woodhouse PR, Meade TW, Khaw KT. Plasminogen activator inhibitor-1, the acute phase response and vitamin C. Atherosclerosis 1997;133:71-6.
132. Weber C, Wolfgang E, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996;93:1488-92.
133. Adams MR, Jessup W, Celermajer DS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C. J Am Coll Cardiol 1997;29:491-7.
134. Lehr H, Frei B, Arfors K. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A 1994;91:7688-92.
135. Lehr HA, Weyrich AS, Saetzler RK, et al. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest 1997;99:2358-64.
136. Lehr H, Frei B, Olofsson M, Carew TE, Arfors K. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 1995;91:1525-32.
137. Moran JP, Cohen L, Greene JM, et al. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr 1993;57:213-7.
138. Jacques PF. A cross-sectional study of vitamin C intake and blood pressure in the elderly. Int J Vitam Nutr Res 1992;62:252-5.
139. Ness AR, Khaw KT, Bingham S, Day NE. Vitamin C status and blood pressure. J Hypertens 1996;14:503-8.
140. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97:22-8.
141. Levine GL, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107-13.
142. Heitzer T, Just H, Munzel T, Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94:6-9.
143. Motoyama T, Kawano H, Kugiyama K, et al. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C. Am J Physiol 1997;273:H1644-50.
144. Ting HH, Timimi FK, Haley EA, Roddy M, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997;95:2617-22.
145. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997;96:1513-9.
146. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;97:363-8.
147. Timimi FK, Ting HH, Haley EA, Roddy M, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998;31:552-7.
148. Kugiyama K, Motoyama T, Hirashima O, et al. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1998;32:103-9.
149. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222-9.
150. Ito K, Akita H, Kanazawa K, et al. Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease. Am J Cardiol 1998;82:762-7.
151. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA 1997;278:1682-6.
152. Vita JA, Frei B, Holbrook M, Gokce N, Leaf C, Keaney JF. L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest 1998;101:1408-14.
153. Hecht SS. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Proc Soc Exp Biol Med 1997;216:181-91.
154. Tannenbaum SR, Wishnok JS. Inhibition of nitrosamine formation by ascorbic acid. Ann N Y Acad Sci 1987;498:354-63.
155. Parsonnet J. Bacterial infection as a cause of cancer. Environ Health Perspect 1995;103:263-8.
156. Satarug S, Haswell-Elkins MR, Tsuda M, et al. Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection. Carcinogenesis 1996;17:1075-81,
157. Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 1991;53(suppl):270S-82S.
158. Fontham ETH. Vitamin C, vitamin C-rich foods, and cancer: epidemiologic studies. In: Frei B, ed. Natural antioxidants in human health and disease. San Diego: Academic Press Inc, 1994:157-97.
159. Jacob RA, Kelley DS, Pianalto FS, et al. Immunocompetence and oxidant defense during ascorbate depletion of healthy men. Am J Clin Nutr 1991;54(suppl):1302S-9S.
160. Hemila H. Vitamin C and infectious diseases. In: Packer L, Fuchs J, eds. Vitamin C in health and disease. New York: Marcel Dekker Inc, 1997:471-503.
161. Vohra K, Khan AJ, Telang V, Rosenfeld W, Evans HE. Improvement of neutrophil migration by systemic vitamin C in neonates. J Perinatol 1990;10:134-6.
162. Johnston CS, Martin LJ, Cai X. Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis. J Am Coll Nutr1992;11:172-6.
163. Levy R, Shriker O, Porath A, Riesenberg K, Schlaeffer F. Vitamin C for the treatment of recurrent furunculosis in patients with impaired neutrophil functions. J Infect Dis 1996;173:1502-5.
164. Maderazo EG, Woronick CL, Hickingbotham N, Jacobs L, Bhagavan HN. A randomized trial of replacement antioxidant vitamin therapy for neutrophil locomotory dysfunction in blunt trauma. J Trauma 1991;31:1142-50.
165. Heuser G, Vojdani A. Enhancement of natural killer cell activity and T and B cell function by buffered vitamin C in patients exposed to toxic chemicals: the role of protein kinase-C. Immunopharmacol Immunotoxicol 1997;19:291-312.
166. Smit MJ, Anderson R. Inhibition of mitogen-activated proliferation of human lymphocytes by hypochlorous acid in vitro: protection and reversal by ascorbate and cysteine. Agents Actions 1990;30:338-43.
167. Haskell BE, Johnston CS. Complement component Clq activity and ascorbic acid nutriture in guinea pigs. Am J Clin Nutr 1991;54(suppl):1228S-30S.
168. Tanaka M, Muto N, Gohda E, Yamamoto I. Enhancement by ascorbic acid 2-glucoside or repeated additions of ascorbate of mitogeninduced IgM and IgG productions by human peripheral blood lymphocytes. Jpn J Pharmacol 1994;66:451-6.
169. Kelley DS, Bendich A. Essential nutrients and immunologic functions. Am J Clin Nutr 1996;63(suppl):994S-6S.
170. Gaziano JM, Manson JE, Hennekens CH. Natural antioxidants and cardiovascular disease: observational epidemiologic studies and randomized trials. In: Frei B, ed. Natural antioxidants in human health and disease. San Diego: Academic Press Inc, 1994:387-409.
171. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Intern Med 1995;123:860-72.
172. Enstrom JE, Kanim LE, Breslow L. The relationship between vitamin C intake, general health practices, and mortality in Alameda County, California. Am J Public Health 1986;76:1124-30.
173. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992;3:194-202.
174. Enstrom JE. Counterpoint - vitamin C and mortality. Nutr Today 1993;28:28-32.
175. Manson JE, Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of vitamin C and incidence of coronary heart disease in women. Circulation 1992;85:865 (abstr).
176. Manson JE, Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. Antioxidant vitamins and incidence of stroke in women. Circulation 1993;87:678 (abstr).
177. Rimm EB, Stampfer MJ, Asherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
178. Fehily AM, Yarnell JWG, Sweetnam PM, Elwood PC. Diet and incident ischaemic heart disease: the Caerphilly Study. Br J Nutr 1993;69:303-14.
179. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-9.
180. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 1995;310:1563-6.
181. Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and carotid artery wall thickness, Circulation 1995;92:2142-50.
182. Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J. Dietary vitamin C and β-carotene and risk of death in middle-aged men. Am J Epidemiol 1995;142:1269-78.
183. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;334:1156-62.
184. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996;64:190-6.
185. Sahyoun NR, Jacques PF, Russell RM. Carotenoids, vitamins C and E, and mortality in an elderly population. Am J Epidemiol 1996;144:501-11.
186. Mark SD, Wang W, Fraumeni JF, et al. Do nutritional supplements lower the risk of stroke or hypertension? Epidemiology 1998;9:9-15.
187. Manson JE, Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. Antioxidant vitamin score and incidence of coronary heart disease in women. Circulation 1991;84:546 (abstr).
188. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991;337:1-5.
189. Eichholzer M, Stahelin HB, Gey KF. Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease and stroke respectively: 12-year follow-up of the Prospective Basel Study. EXS 1992;62:398-410.
190. Gey KF, Stahelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Invest 1993;71:3-6.
191. Singh RB, Ghosh S, Niaz MA, et al. Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol 1995;76:1233-8.
192. Halevy D, Thiery J, Nagel D, et al. Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C. Arterioscler Thromb Vasc Biol 1997;17:1432-7.
193. Nyyssonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997;314:634-8.
194. Vita JA, Keaney JF, Raby KE, et al. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. J Am Coll Cardiol 1998;31:980-6.
195. Simon JA, Hudes ES, Browner WS. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults. Epidemiology 1998;9:316-21.
196. Lykkesfeldt J, Loft S, Nielsen JB, Poulsen HE. Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 1997;65:959-63.
197. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A 1995;92:5258-65.
198. Shekelle RB, Liu S, Raynor WJ, et al. Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet 1981;28:1185-90.
199. Kromhout D. Essential micronutrients in relation to carcinogenesis. Am J Clin Nutr 1987;45:1361-7.
200. Knekt P, Jarvinen R, Seppanen R, et al. Dietary antioxidants and the risk of lung cancer. Am J Epidemiol 1991;134:471-9.
201. Shibata A, Paganini-Hill A, Ross RK, Henderson BE. Intake of vegetables, fruits, β-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 1992;66:673-9.
202. Graham S, Zielezny M, Marshall J, et al. Diet in the epidemiology of postmenopausal breast cancer in the New York State cohort. Am J Epidemiol 1992;136:1327-37.
203. Hunter DJ, Manson JE, Colditz GA, et al. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med 1993;329:234-40.
204. Bostick RM, Potter JD, McKenzie DR, et al. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res 1993;53:4230-7.
205. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92.
206. Kushi LH, Fee RM, Sellers TA, Zheng W, Folsom AR. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am J Epidemiol 1996;144:165-74.
207. Yong L, Brown CC, Schatzkin A, et al. Intake of vitamins E, C, and A and risk of lung cancer. Am J Epidemiol 1997;146:231-43.
208. Stahelin HB, Rosel F, Buess E, Brubacher G. Cancer, vitamins, and plasma lipids: prospective Basel study. J Natl Cancer Inst 1984;73:1463-8,
209. Romney SL, Duttagupta C, Basu J, et al. Plasma vitamin C and uterine cervical dysplasia. Am J Obstet Gynecol 1985;151:976-80.
210. Eichholzer M, Stahelin HB, Gey KF, Ludin E, Bernasconi F. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 1996;66:145-50.
211. Ramaswamy G, Krishnamoorthy L. Serum carotene, vitamin A, and vitamin C levels in breast cancer and cancer of the uterine cervix. Nutr Cancer 1996;25:173-7.
212. Erhola M, Nieminen MM, Kellokumpu-Lehtinen P, Metsa-Ketela T, Poussa T, Alho H. Plasma peroxyl radical trapping capacity in lung cancer patients: a case-control study. Free Radic Res 1997;26:439-47.
213. Webb PM, Bates CJ, Palli D, Forman D. Gastric cancer, gastritis and plasma vitamin C: results from an international correlation and cross-sectional study. Int J Cancer 1997;73:684-9.
214. Gey KF, Brubacher GB, Stahelin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987;45(suppl):1368-77.
215. Stahelin HB, Gey KF, Eichholzer M, et al. Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel study. Am J Epidemiol 1991;133:766-75.
216. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health 1994;84:788-92.
217. Robertson JM, Donner AP, Trevithick JR. Vitamin E intake and risk of cataracts in humans. Ann N Y Acad Sci 1989;570:372-82.
218. Jacques PF, Chylack LT. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991;53(suppl):352S-5S.
219. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and cataract extraction in women: a prospective study. BMJ 1992;305:335-9.
220. Vitale S, West S, Hallfrisch J, et al. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 1993;4:195-203.
221. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies: two nutrition intervention trials. Arch Ophthalmol 1993;111:1246-53.
222. Jacques PF, Taylor A, Hankinson SE, et al. Long-term vitamin C supplement use and prevalence of early age-related lens opacities. Am J Clin Nutr 1997;66:911-6.
223. Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of age-related cataracts. Arch Ophthalmol 1989;107:670-6.
224. Mares-Perlman JA, Klein BE, Klein R, Ritter LL. Relation between lens opacities and vitamin and mineral supplement use. Ophthalmology 1994;101:315-25.
225. Leske MC, Chylack LT, Wu SY. The lens opacities case-control study: risk factors for cataract. Arch Ophthalmol 1991;109:244-51.
226. Leske MC, Chylack LT, He QM, et al. Antioxidant vitamins and nuclear opacities - the longitudinal study of cataract. Ophthalmology 1998;105:831-6.
227. Cohen A, Cohen IJ, Schwartz E. Scurvy and altered iron stores in thalassemia major. N Engl J Med 1981;304:158-60.
228. Marangon K, Herberth B, Lecomte E, et al. Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr 1998;67:231-9.
229. Lykkesfeldt J, Prieme H, Loft S, Poulsen HE. Effect of smoking cessation on plasma ascorbic acid concentration. BMJ 1996;313:91.
230. Kallner AB, Hartmann D, Homig DH. On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers. Am J Clin Nutr 1981;34:1347-55.
231. Smith JL, Hodges RE. Serum levels of vitamin C in relation to dietary and supplemental intake of vitamin C in smokers and non-smokers. Ann N Y Acad Sci 1987;498:144-52.
232. Plodin NW. Vitamin C. In: Pharmacology of micronutrients. New York: Alan R Liss Inc, 1988:201-44.
233. Berger TM, Rifai N, Avery ME, Frei B. Vitamin C in premature and full-term human neonates. Redox Rep 1996;2:257-62.
234. Warsama JW, Launer LJ, Witteman JCM, et al. Dietary antioxidants and cognitive function in a population-based sample of older persons. Am J Epidemiol 1996;144:275-80.
235. Perrig WJ, Perrig P, Stahelin HB. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 1997;45:718-24.
236. Paleologos M, Cumming RG, Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am J Epidemiol 1998;148:45-50.
237. Riviere S, Birlouez-Aragon I, Nourhashemi F, Vellas B. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry 1998;13:749-54.
238. Morris MC, Beckett LA, Scherr PA, et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 1998;12:121-6.